Regulatory Approvals

US FDA approves Lantheus’ brain-imaging agent for Alzheimer’s assessment

By

Regulatory Approvals — US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment  Reuters

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 14, 2026.

By

Related Post

Regulatory Approvals

FDA Approves CELMoD Combination Regimen for Pretreated Multiple Myeloma

Regulatory Approvals

FDA Approves Tau PET Tracer MK-6240 for Alzheimer Diagnostic Workup

Regulatory Approvals

FDA approves new Alzheimer’s PET imaging agent from Lantheus

Financial News For All

Mergers & Acquisitions

Core Scientific Completes Acquisition of Polaris DS, Advancing Planned Muskogee Expansion to 1.5 GW of Gross Power

Mergers & Acquisitions

Paramount-Warner Bros. Merger Gets Mexico’s Approval, Leaving States’ Lawsuit as the Only Barrier Left

Labor

Florida company to lay off nearly 200 workers, close headquarters – The Florida Times

Labor

GM announces layoffs for Lansing Grand River plant retooling